📈 Live Market Tracking
AI-Powered NSE Corporate Announcements Analysis
Acutaas Chemicals Q3 FY26 PAT Surges 133.7% YoY to ₹1,062 Mn; Revenue Guidance Raised to 30%
Acutaas Chemicals reported a stellar Q3 FY26 performance with revenue growing 43% YoY to ₹3,932 million, driven by a robust ramp-up in the CDMO business. Profitability saw a massive jump as EBITDA rose 119.4% to ₹1,507 million, with margins expanding significantly to 38.3% due to favorable product mix and operating leverage. Consequently, PAT grew by 133.7% YoY to reach ₹1,062 million, the highest ever for the company. Management has revised its full-year revenue growth guidance upward to approximately 30% based on a strong order book and improved visibility.
Key Highlights
Revenue from operations grew 43% YoY to ₹3,932 million in Q3 FY26.
EBITDA margins expanded by 1,330 bps YoY to 38.3%, leading to EBITDA of ₹1,507 million.
Net Profit (PAT) increased by 133.7% YoY to ₹1,062 million with a 27% margin.
Management raised FY26 revenue growth guidance from 25% to approximately 30%.
Advanced Intermediates segment remains the primary driver, contributing ₹3,511 million to revenue.
💼 Action for Investors
Investors should view the significant margin expansion and guidance upgrade as a strong bullish signal. The company's strategic pivot into high-growth battery and semiconductor chemicals provides a long-term growth runway.
Acutaas Chemicals Reports Q3 FY26 Results; Auditor Issues Clean Review Report
Acutaas Chemicals Limited, formerly known as Ami Organics Limited, has submitted its standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The independent auditor, Maheshwari & Co., has issued a clean review report, indicating no material misstatements in the financial statements. The consolidated results encompass various subsidiaries including Acutaas Chemicals Electrolytes and Acutaas Advance Material, as well as joint ventures. This filing confirms the company's adherence to SEBI's regulatory reporting requirements.
Key Highlights
Acutaas Chemicals (formerly Ami Organics) filed financial results for the period ended December 31, 2025.
Independent Auditor Maheshwari & Co. issued an unmodified review report for both standalone and consolidated financials.
The consolidated entity includes subsidiaries such as Baba Fine Chemicals and step-down subsidiaries like Indichem Inc.
Financial statements were prepared in accordance with Ind AS 34 (Interim Financial Reporting) and SEBI Regulation 33.
The board meeting for the approval of these results was concluded on January 28, 2026.
💼 Action for Investors
Investors should review the detailed profit and loss statements once fully published to assess revenue and margin performance. The clean audit report provides confidence in the company's financial reporting integrity.